Period Pills for Menstrual Regulation: A New Reproductive Health Option

Part of paid clinical trials in Oakland, California.

Sponsor
University of California, San Francisco
Study ID
NCT07671989
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Menstrual Health Intervention
  • Menstrual Regulation

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Mifepristone + Misoprostol — DRUG
    Study participants are given mifepristone and misoprostol for menstrual regulation.

Study Details

The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.

Key Dates

Start date
Jun 22, 2026
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
May 31, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Study Participants
    Study participants will be persons who have late period of up to 21 days

Primary Outcome Measure

Interest in period pills [ Time Frame: Documented at Enrollment Survey ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
UCSF Advancing New Standards in Reproductive Health (ANSIRH)OaklandCalifornia94612-
Roanoke Health CenterRoanokeVirginia24017
Christine Hernández, MPH, MPM, CPHQ
[email protected]
828-280-5723
Matthew Zerden, MD, MPH
[email protected]
617-935-2394

Find similar trials in Oakland, CA

By research site
UCSF Advancing New Standards in Reproductive Health (ANSIRH)· Oakland, CARoanoke Health Center· Roanoke, VA